ABOUT US
RPEXBIO is a pioneering company specializing in cutting-edge RNA-based vaccine and therapy development.
With extensive expertise in research, clinical trials, and manufacturing, we are
dedicated to advancing healthcare through innovative solutions
TECHNOLOGY
PIPLINE
RPEXBIO is striving to develop advanced RNA-based biologics, with ongoing efforts focused on the development of cutting-edge vaccines, including a safety-enhanced COVID-19 mRNA vaccine and a ZIKA virus attenuated vaccine
VIEW MORE
